CA3296442A1 - Forme cristalline - Google Patents

Forme cristalline

Info

Publication number
CA3296442A1
CA3296442A1 CA3296442A CA3296442A CA3296442A1 CA 3296442 A1 CA3296442 A1 CA 3296442A1 CA 3296442 A CA3296442 A CA 3296442A CA 3296442 A CA3296442 A CA 3296442A CA 3296442 A1 CA3296442 A1 CA 3296442A1
Authority
CA
Canada
Prior art keywords
crystalline form
crystalline
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CA3296442A
Other languages
English (en)
Inventor
Helene Greciet
Olivier Monnier
Isabelle Ziri
Jakub Tadeusz FLASZ
Sabrina Raymonde Sophie GRAFFEO
Céline ROUGEOT
Original Assignee
UCB Biopharma SRL
Sanofi SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by UCB Biopharma SRL, Sanofi SA filed Critical UCB Biopharma SRL
Publication of CA3296442A1 publication Critical patent/CA3296442A1/fr
Pending legal-status Critical Current

Links

CA3296442A 2023-07-04 2024-07-03 Forme cristalline Pending CA3296442A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP23183371.6 2023-07-04

Publications (1)

Publication Number Publication Date
CA3296442A1 true CA3296442A1 (fr) 2025-01-09

Family

ID=

Similar Documents

Publication Publication Date Title
CA3281023A1 (en) Crystalline psilacetin derivatives
EP4110786A4 (fr) Fumarate de bis-miprocine cristallin
AU2024290368A1 (en) Crystalline form
EP4377309A4 (fr) Formes cristallines
CA3296442A1 (fr) Forme cristalline
CA3285643A1 (fr) Forme cristalline
CA3275072A1 (fr) Formes cristallines de 2-oxoquinazoline
HK40107970A (en) Crystalline forms
HK40115487A (en) Novel crystalline forms
HK40111070A (en) Crystalline intermediates
EP4452958A4 (fr) Intermédiaires cristallins
AU2021904153A0 (en) Crystalline Intermediates
HK40116601A (en) Crystalline form of lanifibranor
CA3267523A1 (fr) Formes cristallines de psilocine
HK40096047A (en) Crystalline form of aspacytarabine
CA3279113A1 (fr) Nanoparticules cristallines comprenant de l'enzalutamide
HK40082031A (en) Crystalline form of lnp023
CA3268342A1 (fr) Composé de triphénylazole
CA3305167A1 (fr) Composés ciblant la survivine
CA3301857A1 (fr) Composés contenant du cyclobutyle
CA3295511A1 (en) Compounds
CA3295507A1 (fr) Composés
CA3283976A1 (fr) Composés
AU2023903954A0 (en) Compounds
CA3275025A1 (fr) Composés